[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Arrowhead Research Corporation (ARWR)
Arrowhead Research Corporation (ARWR) files CTA for ARO-DIMER-PA, a dual RNAi therapeutic, but faces negative pressure due to market volatility. Social media buzzes with both excitement over the new developments and concerns about valuation and market manipulation, creating a mixed sentiment around the stock's future trajectory.
About Arrowhead Research Corporation
Arrowhead Research Corporation (ARWR) is a biopharmaceutical company focused on RNA interference (RNAi) based medicines.
Arrowhead Research Corporation uses the ticker $ARWR for trading. Listed in the Stocks and category within the Healthcare sectors.
Insights #
- Arrowhead Research Corporation (ARWR) trading volume is up XXXXXX% from the previous X months.
- Arrowhead Research Corporation (ARWR) creators is up XXXXX% from the previous week.
Price: $XX #
Price 24-Hour Time-Series Raw Data
The current price decrease of -XXXX% is likely influenced by overall market volatility, which seems to be overriding positive sentiment from analyst ratings and Phase X enrollment. The negative price action is also influenced by the top social posts mentioning ARWR as a loser stock.
| 24-Hour | 7-Day | 30-Day |
|---|---|---|
| -XXX% | -XXXX% | XXXXX% |
1-Year High: $XXXXX on 2025-10-06
1-Year Low: $XX on 2025-04-08
AltRank: XXX #
AltRank 24-Hour Time-Series Raw Data
Arrowhead Research Corporation (ARWR) is currently AltRank #136 based on combined combined social and market metrics
Daily Average: XXX
1 Week: XXXXX +660
1 Month: XXX -XX
6 Months: XXX -XXXXX
1 Year: XXX -XXX
1-Year High: XXXXX on 2025-05-30
1-Year Low: XX on 2025-09-03
Galaxy Score: XX #
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1 Week: XX -XX
1 Month: XX -XX
6 Months: XX -XX
1 Year: XX -XX
1-Year High: XX on 2025-09-02
1-Year Low: XX on 2025-09-16
Engagements: XXXXX #
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXXX
1 Week: XXXXXX -XX%
1 Month: XXXXXXX -XX%
6 Months: XXXXXXXXX +3.90%
1 Year: XXXXXXXXX +49%
1-Year High: XXXXXXX on 2024-11-26
1-Year Low: XXX on 2025-10-15
| Social Network | X |
|---|---|
| Engagements | XXXXX |
Mentions: XX #
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
1 Week: XXX -XXXX%
1 Month: XXX -XX%
6 Months: XXXXX -XXXX%
1 Year: XXXXX +193%
1-Year High: XXX on 2024-12-03
1-Year Low: XX on 2025-10-15
| Social Network | X |
|---|---|
| Mentions | XXX |
Creators: XX #
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Arrowhead Research Corporation (ARWR) in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX
1 Week: XX +10%
1 Month: XXX -XX%
6 Months: XXXXX +35%
1 Year: XXXXX +142%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-10-15
The most influential creators that mention Arrowhead Research Corporation in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @Quantumup1 | X | XXXXX | X | XXXXX |
| @Biobeats99 | X | XXX | XX | XXX |
| @linhnguyen64143 | X | XX | X | XX |
| @MarcJacksonLA | X | XXXXX | X | XX |
| @TTRAmyloid | X | XXXXX | X | XX |
| @Hall8Jack | X | XXXXX | X | XX |
| @BIOTECHBATMAN | X | XXX | X | X |
| @TheSliv | X | XXX | X | X |
| @Tautilas | X | XXXXX | X | X |
Sentiment: XX% #
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -XX%
1 Month: XXX% +44%
6 Months: XXX% +15%
1 Year: XXX% +17%
1-Year High: XXX% on 2025-06-12
1-Year Low: XX% on 2025-03-20
Most Supportive Themes
- Analyst Ratings and Platform Advantages: (63%) Positive sentiment from analysts' positive price targets and the potential of Arrowhead's TRiM platform.
- Pipeline and Drug Development: (31%) Positive sentiment regarding Arrowhead's pipeline advancements and new drug developments.
Most Critical Themes
- Valuation Concerns & Short Squeeze: (6%) Concerns about market manipulation and perceived undervaluation are present in the social posts.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXXXX | XX% | XXXXX | XX% | XX | X% |
| Total | XXXXX | XX% | XXXXX | XX% | XX | X% |
Social Dominance: XXXXXXX% #
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: XXXXX%
1 Week: XXXXXXX% -XXXXXXX%
1 Month: XXXXX% -XXXXX%
6 Months: XXXXX% -XXXXXXXXXXXXXXXXXXXXX%
1 Year: XXXXX% -XXXXX%
1-Year High: XXXX% on 2024-12-03
1-Year Low: XXXXXX% on 2025-10-12
Market Dominance: XXXXXXX% #
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-10-12
1-Year Low: XXXXXXX% on 2025-10-14
Market Cap: $XXXXXXXXXXXXX #
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXX -$3%
1 Month: $XXXXXXXXXXXXX +$21%
6 Months: $XXXXXXXXXXXXX +$222%
1 Year: $XXXXXXXXXXXXX +$107%
1-Year High: $XXXXXXXXXXXXX on 2025-10-06
1-Year Low: $XXXXXXXXXXXXX on 2025-04-08
Top assets mentioned In the posts about Arrowhead Research Corporation in the last XX hours
Incyte Corporation (INCY) Moderna Inc (MRNA) Regeneron Pharmaceuticals Inc (REGN) BioMarin Pharmaceutical, Inc. (BMRN) Ionis Pharmaceuticals, Inc. Common Stock (IONS) Avidity Biosciences, Inc. Common Stock (RNA) Novartis AG (NVS) uniQure N.V. (QURE) Dyne Therapeutics, Inc. Common Stock (DYN)
Top topics mentioned In the posts about Arrowhead Research Corporation in the last XX hours
stocks healthcare, $incy, $mrna, regeneron pharmaceuticals inc, investment, coins defi, $bmrn, $ions, telegram, coins dao, $rna, stocks technology, novartis, $novnsw, $qure, dyne therapeutics, $exel, $crsp, pika, alnylam pharmaceuticals inc, $beam, $adpt, $cort, $ntla, $rytm, $mrus, $pepg, coins bsc, $cytk, $aauc, $abat, $acmr, $prgo, stocks financial services, momentum, $bbio, $rvmd, stocks consumer cyclical, $apge, $xene, $abbv, $abcl, $amgn, $rgnx, $akro, $pcvx, $ptct, $sdgr, $blue, $xbi, $glue, coins solana ecosystem, $wve, $nvs, $alny, files, af, $howl, $tecx, $brns, united therapeutics corp, $nvda, $klrs, united states, $bntx, $mnkd, regency centers corp, stocks real estate, $reg, $odp, goldman sachs, $gs, stocks consumer defensive, $insm, $vera, $asmb, $atmu, $atro, $aca, $elan, $roiv, $rgc, acquisition, $10s, dip, $plug, stocks industrials, market cap, $krys, $1b, stocks bitcoin miners, $alhc, $cmps, $llc, $sln, coins base ecosystem, $axsm, $nuvl, $kura, underway
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Citizens JMP PRQR: ProQR Therapeutics N.V. - Dinner with CFO of ProQR (Jonathan Wolleben) Full report in Telegram (in bio)☝ (Tickers: $PRQR $IONS $ALNY $ARWR $DYN $BNTX)"
X Link @Biobeats99 2025-10-14T23:13Z XXX followers, XXX engagements
"WB $DNLI Tivi Priority Review PDUFA Extended Due to Clinical Pharmacology Request Full report in Telegram (in bio)👆 $BLUE $ARWR $VRTX $BMRN $SRPT $IONS $ALNY $EDIT $CRSP $NTLA $BEAM $RGNX $QURE $ABEO $PGEN $FATE $SGMO $ADVM $VERV $PRAX $GLPG $NBIX $ACAD $RARE $VKTX $MOR $ZLAB"
X Link @Biobeats99 2025-10-13T23:18Z XXX followers, XXX engagements
"Barclays CRSP - ESGCT update for CTX460 supports pre-clinical proof of concept in AATD Full report in Telegram (in bio)☝ (Tickers: $WVE $NTLA $CRSP $BEAM $ARWR $QURE)"
X Link @Biobeats99 2025-10-13T22:59Z XXX followers, XXX engagements
"Healthcare / Biotech watchlist for the week: $ATAI $GRAL $RAPT $LCTX $ARWR $OLMA $ESPR"
X Link @nofinncialadvce 2025-10-13T17:28Z XX followers, XXX engagements